KRM Ayurveda Limited, incorporated in 2019, operates in the Ayurvedic healthcare and wellness space. The company runs a network of Ayurvedic hospitals and clinics offering treatments, consultancy, and wellness solutions. It earns revenue through in-patient and out-patient services, Panchakarma therapies, sale of Ayurvedic medicines, wellness packages, and teleconsultation services. The company focuses on chronic lifestyle and metabolic disorders using classical Ayurvedic formulations and personalized care.

Key Clients and Manufacturing / Operational Facilities

KRM Ayurveda primarily serves individual patients across India and overseas through teleconsultation. Its facilities include 6 hospitals and 5 clinics located in cities such as Delhi, Noida, Mumbai, Patna, and Lucknow. These facilities are equipped with consultation chambers, Panchakarma units, herbal pharmacies, diet kitchens, yoga and meditation halls, and in-patient beds, enabling integrated Ayurvedic healthcare delivery.

Product Portfolio, Order Book & Execution

The company’s portfolio includes Ayurvedic treatments, Panchakarma therapies, wellness programs, diet and lifestyle counselling, and trading of Ayurvedic medicines, oils, and supplements. These products address chronic diseases like kidney disorders, diabetes, arthritis, and liver ailments across patient life cycles. Orders are executed through hospitals, clinics, and telemedicine platforms, ensuring continuous patient engagement and repeat treatment-based revenue.

Mergers, Capex & Expansion Plans

KRM Ayurveda has converted from a private to a public limited company in December 2024 to support future growth. The company plans expansion through the establishment of new hospitals and clinics, capacity enhancement, and technology-driven teleconsultation services. Proposed capital expenditure will focus on infrastructure development, service expansion, and strengthening its pan-India and global digital healthcare presence.

Employees and Banker to the Company

As on December 31, 2025, the Company had 443 employees. The Banker to the Company is ICICI Bank Limited.

KRM Ayurveda is led by experienced promoters and professional management with deep expertise in Ayurvedic healthcare. The management aims to scale operations through hospital and clinic expansion, digital healthcare delivery, and product portfolio growth. Short-term focus includes strengthening operational efficiency and profitability, while long-term goals include becoming a leading Ayurvedic healthcare brand. Capex and expansion will be funded through IPO proceeds, internal accruals, and optimized debt management.

INDUSTRY OVERVIEW

KRM Ayurveda operates in the AYUSH and Ayurvedic healthcare industry. The Indian AYUSH market is valued at USD 43.4 billion and is expected to grow to USD 200 billion by 2030, indicating nearly 8x growth. The industry recorded a CAGR of 31.47% from 2014–15 to 2020. Ayurveda manufacturing alone is projected to grow from USD 18 billion (2020) to USD 24 billion by 2024. India exports AYUSH products worth USD 1.54 billion to over 150 countries, highlighting strong global demand.

KEY RISK FACTORS

1. Regulatory Risk
   The company operates in a regulated healthcare environment. Any adverse changes in AYUSH regulations, licensing norms, or compliance requirements could impact hospital operations, service delivery, and expansion plans.
2. Dependence on Skilled Professionals
   KRM Ayurveda’s business depends heavily on qualified Ayurvedic doctors and therapists. Shortage, attrition, or inability to retain skilled professionals may affect service quality and patient trust.
3. Competition Risk
   The Ayurvedic healthcare sector is highly competitive, with increasing participation from hospitals, wellness centers, and large healthcare groups. This may impact pricing power and market share.
4. Geographic Concentration Risk
   A significant portion of operations is concentrated in select Indian cities. Any regional disruptions, policy changes, or demand slowdown may adversely affect revenues.
5. Technology & Data Security Risk
   The company relies on third-party CRM and HMS software systems. Any data breach, system failure, or cyber security issue could disrupt operations and harm reputation.

SECTION 5: KEY STRENGTHS, MOAT & OPPORTUNITIES

1. Integrated Ayurvedic Healthcare Model
   KRM Ayurveda offers end-to-end services including hospitals, clinics, medicines, and teleconsultation, creating a strong integrated healthcare ecosystem and patient retention advantage.
2. Strong Financial Performance
   The company reported ₹76.95 crore revenue in FY25 with EBITDA margin of 27.74% and PAT margin of 16.60%, reflecting operational efficiency and improving profitability.
3. High-Growth Industry Tailwinds
   With the Indian AYUSH market expected to grow to USD 200 billion by 2030, the company is well-positioned to benefit from rising demand for natural and holistic healthcare.
4. Teleconsultation & Global Reach
   Telemedicine services enable KRM Ayurveda to serve international and remote patients, improving scalability and reducing dependence on physical infrastructure.
5. Specialization in Chronic Disorders
   Focus on chronic and lifestyle diseases such as kidney disorders, diabetes, and arthritis ensures repeat treatments, long patient life cycles, and stable revenue streams.
6. Government Support for AYUSH
   Strong government backing through the Ministry of AYUSH and national programs provides long-term policy support, funding opportunities, and industry credibility.